Nashville-based healthcare analytics firm Trilliant Health has landed its sixth major investor, with plans to grow and expand the company’s predictive analytics platform.
Bon Secours Mercy Health, based in Cincinnati, has joined Primus Capital, Providence Ventures, Martin Ventures, Noro-Moseley Partners and Nashville Capital Network as a strategic growth investor in the company, which uses data to guide the strategy of health care providers on how to increase the market share.
The dollar value of the investment in Trilliant was not disclosed in a press release. As part of the transaction, Deepesh Chandra, chief analysis officer of Bon Secours, will serve on the company’s board of directors.
“At a time of unprecedented disruption in the U.S. healthcare system, Trilliant Health provides healthcare systems with critical insight into the national and local trends shaping the healthcare economy,” said Brian Smith, President and CEO of operation of Bon Secours Mercy Health, in the press release. .
“Healthcare providers increasingly need advanced analytics for every business decision,” he continues. “Trilliant Health is a leader in this area, and we view this investment as an important step in how we will use data to serve our mission, patients and communities. “
Founded in 2019 through a merger between Aegis and Clariture, Trilliant’s management sold a majority stake in the company to Cleveland-based Primus in 2019. Since then, Trilliant hired Johns Hopkins professor Sanjula Jain will lead the company’s long-term strategy and research as the industry undergoes a radical transformation.